p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts

Molecular and Cellular Biology

Volumn 19, Issue 11, 1999, Pages 7621-7629

  Reynaud, Emmanuel G ^a   Pelpel, Karine ^a   Guillier, Martine ^a   Leibovitch, Marie Pierre ^a   Leibovitch, Serge A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CYCLIN DEPENDENT KINASE; CYCLIN E; MYOD PROTEIN; PROTEIN P57; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; MOLECULAR CLONING; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

ANIMALIA;

EID: 0032695604     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.11.7621     Document Type: Article

References (63)

1. rat proto-oncogene product enhances the positive autoregulatory loop of MyoD. FEBS Lett. 437:39-43.
2. Benezra, R., R. Davis, D. Lockson, D. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-69.
3. Boussif, O., F. Lezoualc'h, M. A. Zanta, M. D. Mergy, D. Scherman, B. Demeneix, and J. P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92:7297-7301.
4. Braun, T. E., G. Buschhausen-Denker, E. Bober, E. Tannich, and H. Arnold. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8:701-709.
5. Braun, T. E., G. Bober, G. Buschhausen-Denker, S. K. Kotz, H. Grzeschik, and H. Arnold. 1989. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J. 8:3617-3625.
6. Buskin, J. N., and S. D. Hauschka. 1989. Identification of a myocyte nuclear factor which binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol. Cell. Biol. 9:2627-2640.
7. Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
8. Davis, R. L., P. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle specific gene activation. Cell 60:733-746.
9. Deed, R. W., E. Hara, G. T. Atherton, G. Peters, and J. D. Norton. 1997. Regulation of Id3 cell cycle function by Cdk2-dependent phosphorylation. Mol. Cell. Biol. 17:6815-6821.
10. Cip1/WAF1 undergo normal development but are defective in G1 checkpoint control. Cell 82:675-684.
11. Eckner, R., T. P. Yao, E. Odlread, and D. M. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478-2490.
12. Edmondson, D. G., and E. N. Olson. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640.
13. Kip1-deficient mice. Cell 85:733-744.
14. Gu, W., J. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
15. Guo, K., J. Wang, V. Andres, R. C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
16. Guo, K., and K. Walsh. 1997. Inhibition of myogenesis by multiple cyclin-cdk complexes. J. Biol. Chem. 272:791-797.
17. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
18. Hardy, S., Y. Kong, and S. F. Konieczny. 1993. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain. Mol. Cell. Biol. 13:5943-5956.
19. Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56-64.
20. Kip2 in cyclin-dependent kinase2 inhibition and growth suppression. J. Biol. Chem. 273: 16544-16550.
21. Hatoum, O. A., S. Gross-Mesilaty, K. Breitschopf, A. Hoffman, H. Gonen, A. Ciechanover, and E. Bengal. 1998. Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: regulation by specific DNA binding. Mol. Cell. Biol. 18:5670-5677.
22. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. 8:28-35.
23. Kitzmann, M., M. Vandromme, V. Schaeffer, G. Carnac, J. C. Labbé, N. Lamb, and A. Fernandez. 1999. cdk1/2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity. Mol. Cell. Biol. 19:3167-3176.
24. Kip1. Cell 85:721-713.
25. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639-649.
26. Kip1 in neurons. Proc. Natl. Acad. Sci. USA 93:3259-3263.
27. Leibovitch, S. A., M. Guillier, J. L. Lenormand, and M. P. Leibovitch. 1991. Accumulation of the c-mos protein is correlated with post-natal development of skeletal muscle. Oncogene 6:1617-1622.
28. Lenormand, J. L., M. Guillier, and S. A. Leibovitch. 1993. Identification of a cis acting element responsible for muscle specific expression of the c-mos proto-oncogene. Nucleic Acids Res. 21:695-702.
29. Lenormand, J. L., B. Benayoun, M. Guillier, M. Vandromme, M. P. Leibovitch, and S. A. Leibovitch. 1997. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins. Mol. Cell. Biol. 17:583-593.
30. Li, L., J. Zhou, G. James, R. Heller-Harrison, M. P. Czech, and E. N. Olson. 1992. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71:1181-1194.
31. Li, L., R. Heller-Harrison, M. P. Czech and E. N. Olson. 1992. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol. Cell. Biol. 12:4478-4485.
32. Liu, M., M. H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman. 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 9:650-662.
33. Cip1 CDK inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
34. Miner, J. H., and B. Wold. 1990. Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. USA 87:1089-1093.
35. Molkentin, J. D., B. L. Black, J. F. Martin, and E. M. Olson. 1995. Cooperative interaction of muscle expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136.
36. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD and myc proteins. Cell 56:777-783.
37. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, and A. B. Lassar. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
38. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
39. Olson, E. N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Genes Dev. 4:1454-1461.
40. Olson, E. N. 1992. Proto-oncogenes in the regulatory circuit for myogenesis. Semin. Cell Biol. 3:127-136.
41. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
42. Kip1 a cyclin-Cdk inhibitor and a potential mediator of extracellular antimitotic signal. Cell 78:59-66.
43. Rao, S. S., C. Chu, and D. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
44. Resnisdottir, I., K. Polyak, A. Iavaronne, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831-1845.
45. Rhodes, S. J., and S. F. Konieczny. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3:2050-2061.
46. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclinA-Cdk2 complex. Nature 382:325-331.
47. Serrano, M., H. W. Lee, C. Cordon-Cardo, D. Beach, and R. Delinho. 1996 Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37.
48. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
49. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
50. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
51. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin-D1-dependent kinase. Science 267:1022-1024.
52. Song, A., Q. Wang, M. G. Goebl, and M. A. Harrington. 1998. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell. Biol. 18:4994-4999.
53. Sorrentino, V., R. Pepperkok, R. L. Davis, W. Ansorge, and L. Philipson. 1990. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature 345:813-815.
54. Tapscott, S. J., R. L. Davis, M. J. Thayer, P. Cheng, H. Weintraub, and A. B. Lassar. 1988. MyoD1: a nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242:405-411.
55. Thayer, M. J., S. J. Tapscott, R. L. Davis, W. E. Wright, A. B. Lassar, and H. Weintraub. 1989. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58:241-248.
56. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74.
57. Weinberg, R. A. 1995. The retinoblastoma protein and the cell cycle control. Cell 81:323-330.
58. Weintraub, H., S. J. Tapscott, R L. Davis, M. J. Thayer, M. A. Adam, A. B. Lassar, and A. D. Miller. 1989. Activation of muscle specific genes in pigment, nerve, fat, liver and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA 86:5434-5438.
59. Wright, W. E., D. A. Sassoon, and V. K. Lin. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607-617.
60. Xiong, Y. 1996. Why are there so many CDK inhibitors? Biochim. Biophys. Acta 1288:1-5.
61. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Gene Dev. 11:973-983.
62. Kip2 indicates a role in Beckwith-Wiedeman syndrome. Nature 387:151-158.
63. Zhang, J.-M., Q. Wei, X. Zhao, and B. M. Paterson. 1999. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with Cdk4. EMBO J. 18:926-933.